通过基突变发生的新型氨酸和氨酸受体激活剂的开发
1Department of Medicinal Biotechnology, College of Health Science, Dong-A University, Busan, 49315, Republic of Korea.
Archives of biochemistry and biophysics
|October 31, 2024
概括
研究人员开发了新的氨酸类类似物,可显著增强氨酸和氨酸受体激活. 这些强大的激活剂在治疗肥胖和相关代谢障碍方面表现有前途.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸激素受体包括素激素受体和辅助蛋白质.
- 素受体激活调节的平衡,是氨酸受体功能的核心.
- 大脑中的氨基林受体激活会影响血糖和食欲控制,使其成为肥胖症治疗的目标.
研究的目的:
- 开发用于人类氨酸和氨酸受体的新型,强大的激活剂.
- 提高氨酸类型的亲和力和疗效,用于治疗肥胖和代谢障碍的治疗应用.
主要方法:
- 综合性突变发生应用于大鼠氨酸,以创建修改后的类似物.
- 鼠类氨酸的C端片段被用于选针对氨酸受体细胞外域的亲和力增强突变.
- 测试了突变类型的同类药物,以增加激活人类氨酸和氨酸受体的亲和力和功效.
主要成果:
- 十二种突变组合显著增加了百倍以上的氨酸和氨酸受体细胞外域的化亲和力.
- 三种代表性的37氨基酸老鼠氨酸类似物,与内源性老鼠氨酸相比,其效能增加了5到10倍.
- 开发的突变激活剂对人类氨酸和氨酸受体的强度高于可用的激活剂pramlintide.
结论:
- 成功开发了新型大鼠氨酸类似物,对氨酸和氨酸受体具有显著增强的亲和力和功效.
- 这些工程激活剂代表了在基于细胞的系统中激活氨酸受体的宝贵药理工具.
- 这些发现表明,这些类似物在通过氨酸受体调节来管理肥胖和相关的代谢状况方面具有潜在的治疗应用.
相关概念视频
Glucagon-like Receptor Agonists
300
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
300
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


